Recent studies have suggested that mutations affecting driver genes and driver genetic alterations are homogeneously distributed within some cancer types (for example, EGFR, KRAS, and TP53 mutations in non-small cell lung cancers) [54,55]. The gene discussed is KRAS; the disease is cancer.